The loss of sphere-forming capacity and efficacy of tumour formation for CD24- MM cells can be linked to their loss of several other stemness markers, including CD47, EpCAM and OCT4, as shown for the tumour tissue. Here, EPCAM is linked to Miyoshi myopathy.